Treatment of Osteoporosis with 1‐Alpha‐Hydroxycholecalciferol and Calcium

Authors:

Abstract
A double‐blind comparative study of 1α‐OHD3 and placebo was performed on 37 patients with osteoporotic hip fracture without clinical osteomalacia. 1α‐OHD3, in a dose of 1 μg/day together with 2.5 g CaCO3 did not heal osteoporosis as judged from determinations of bone mineral density and histomorphometric analyses during four months of treatment. However, 1α‐OHD3 seemed to have an effect on fracture healing as concluded from the posttreatment alkaline phosphatase level. Hypercalcemia was common, occurring in six out of 19 patients treated with 1α‐OHD3. It is concluded that treatment of osteoporosis with 1α‐OHD3 and calcium is ineffective and potentially dangerous because it frequently causes hypercalcemia.

This publication has 10 references indexed in Scilit: